Every 10-Q that Ziff Davis, Inc. (ZD) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow ZD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ZD filings page.
Ziff Davis, Inc. reported Q2 2026 revenues from continuing operations of $286.7 million, down from $294.8 million a year earlier, and a net loss from continuing operations of about $52.2 million, or $1.43 per share, mainly due to a $54.8 million goodwill impairment in its Health & Wellness segment.
Results were dominated by the completed sale of the Connectivity business to Accenture, which generated total proceeds of approximately $1,216.1 million and a pre-tax gain of $860.6 million. Net income from discontinued operations was $676.6 million, lifting overall net income to $624.5 million, or $17.16 per share.
Cash and cash equivalents rose to about $1.61 billion while total debt remained near $872.3 million, alongside an undrawn $350.0 million revolving credit facility. The company repurchased and retired 3.8 million shares in the first half, reducing common shares outstanding to 34.96 million and increasing stockholders’ equity to $2.24 billion.
Ziff Davis, Inc. reported first-quarter 2026 total revenues of $267.6 million, slightly below $272.8 million a year earlier, and generated operating income of $2.9 million. Continuing operations produced a small net loss of $0.8 million, but discontinued operations contributed net income of $23.0 million, leading to overall net income of $22.3 million or $0.59 per diluted share.
A key event was a definitive agreement to sell the Connectivity business to Accenture for $1.2 billion in cash, with the unit now classified as held for sale and reported as discontinued operations. As of March 31, 2026, Ziff Davis held $519.7 million of cash and cash equivalents in continuing operations and had total notes outstanding of $872.3 million.
The company generated $30.0 million of net cash from operating activities, spent $33.1 million on capital expenditures, and used $51.6 million for common stock repurchases. Shares outstanding declined to 37.4 million at quarter-end, supported by an expanded repurchase authorization covering up to 25 million shares through 2036.
Ziff Davis (ZD) filed its Q3 2025 10‑Q, reporting total revenues of $363.7 million, up slightly from $353.6 million a year ago. Income from operations was $28.4 million versus a loss of $29.3 million last year, reflecting tighter operating performance.
The quarter closed with a net loss of $3.6 million, narrower than the $48.6 million loss a year ago, primarily after a $17.6 million goodwill impairment and a $17.6 million provision for credit losses on an available‑for‑sale corporate debt security. For the first nine months, revenue reached $1.04 billion and net income was $47.0 million, compared to a small loss in the prior year period.
Operating cash flow was strong at $216.0 million year‑to‑date. The company repurchased $113.2 million of common stock in the first nine months, with 39,993,208 shares outstanding at September 30, 2025 and 39,504,872 shares as of November 4, 2025. Ziff Davis completed seven immaterial acquisitions for total consideration of $81.6 million (net $76.4 million) and sold its minority interest in OpenEvidence for $29.7 million. Long‑term debt was $865.9 million, unchanged in principal.